Vistagen Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
VTGN on Nasdaq
Location
343 Allerton Avenue, South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 10/8/2024

Vistagen Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Venrock Healthcare Capital Partners II, L.P. 10%+ Owner $35.4M Jul 12, 2022
Commodore Capital Lp 10%+ Owner $2.7M Oct 4, 2023
H. Ralph Snodgrass Pres./Chief Scientific Officer $170K Dec 31, 2021
Shawn Singh President and CEO, Director $79.5K Jun 30, 2025
Reid G. Adler Chief Legal Officer $40.9K Jun 30, 2025
Mark Alan Smith Chief Medical Officer $34.2K Jun 30, 2022
Cynthia Anderson Chief Financial Officer $21.8K Jun 30, 2025
Joshua S. Prince Chief Operating Officer $18.5K Jun 30, 2025
Jerrold D. Dotson Vp, Cfo $6.3K Jun 30, 2023
Jerry B. Gin Director Sep 6, 2024
Margaret M. FitzPatrick Director Sep 9, 2025
Joanne Curley Director Sep 9, 2025
Mary L. Rotunno Director Sep 9, 2025
Ann Michelle Cunningham Director Sep 9, 2025
Jon S. Saxe Director Sep 9, 2025
Elissa S. Cote Chief Corp Development Officer Jun 23, 2025

Recent Insider Transactions by Companies or Individuals for Vistagen Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.